Journal of Diabetology is a publication of Diabetes In Asia Study Group (DASG). The DASG is a non-profit organization, which was established in 2006. DASG is a continuation of the earliest Diabetes in Asia Conferences, a movement which was started in 1999. The aim of DASG is to promote education and awareness of diabetes in countries within Asia and the Middle East, to encourage research in the field of diabetes and related disorders, to promote exchanges of opinions and Scientists and to foster advocacy regarding diabetes in the region. This in turn would lead to better strategies for diagnosis, care and prevention of diabetes. One of the strategies of DASG to achieve its objectives is to hold periodic meetings and conferences and to promote the publications of research activities in diabetes. In this view, the Journal of Diabetology, was started as a peer-reviewed online free journal with 3 issues annually. The journalís full text is available online at http://www.journalofdiabetology.org. The journal allows free access (Open Access) to its contents and permits authors to self-archive final accepted version of the articles on any OAI-compliant institutional / subject-based repository.
Journal of Diabetology, a publication of Diabetes In Asia Study Group, is a peer-reviewed online 3 Issues journal. The journalís full text is available online at http://www.journalofdiabetology.org. The journal allows free access (Open Access) to its contents and permits authors to self-archive final accepted version of the articles on any OAI-compliant institutional / subject-based repository.
Abstracting and Indexing Information
The journal is registered with the following abstracting partners:
Baidu Scholar, CNKI (China National Knowledge Infrastructure), EBSCO Publishing's Electronic Databases, Ex Libris Ė Primo Central, Google Scholar, Hinari, Infotrieve, National Science Library, Netherlands ISSN center , ProQuest, TdNet, Wanfang Data
The journal is indexed with, or included in, the following:
Wolters Kluwer and Journal/Association are committed to meeting and upholding standards of ethical behavior at all stages of the publication process. We follow closely the industry associations, such as the Committee on Publication Ethics (COPE), International Committee of Medical Journal Editors (ICMJE) and World Association of Medical Editors (WAME), that set standards and provide guidelines for best practices in order to meet these requirements. For a summary of our specific policies regarding duplicate publication, conflicts of interest, patient consent, etc., please visit www.Medknow.com/EthicalGuidelines.asp
Open Access Publication and Creative Commons Licensing
This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
Wolters Kluwer Medknow provides for long-term digital preservation through two primary partnerships, Portico and CLOCKSS.
Portico is a leading digital preservation service worldwide. The content is preserved as an archival version and is not publically accessible via Portico, but is provided when required under specific conditions, such as discontinuation of the collection or catastrophic failure of the website.
CLOCKSS will enable any library to maintain their own archive of content from Wolters Kluwer Medknow and other publishers, with minimal technical effort and using cheaply available hardware.
Ahead of Print policy
Articles published online under the Ahead of Print model are considered published and can be cited and quoted using the DOI as the reference source. Wolters Kluwer Medknow has a policy that changes will not be made after publication of an article without following accepted procedures for making corrections to the scientific record.
While advertisements are crucial to this journal to be able to keep all content free for everyone, ethical considerations are in place to ensure the integrity of the journal and its content:
- "Pop-up" and "banner" ads appear on a random, rotating basis. The advertiser has no control or input over the pages where their ads appear.
- The Editorial Board has full and final approval over the content of all advertisements.
- Advertisers will never be shown any manuscripts or other content prior to publication.
The journal will cover technical and clinical studies related to health, ethical and social issues in field of Clinical, Epidemiology, Complications, Therapy, Screening, Prevention, Diagnostic Methods etc.. Articles with clinical interest and implications will be given preference.